Recent research has shown that cancer patients undergoing bone marrow transplantation (BMT) experience moderate to severe mouth pain due to treatment-related mucositis in spite of morphine therapy. Treatment-related emotional distress in BMT patients is also described widely. This study examined several biomedical, psychological and social variables as possible predictors for the intensity of treatment-related mouth pain and anxious mood in 63 cancer patients undergoing BMT or stem cell transplantation (SCT) within a prospective longitudinal design. Biomedical predictors included biomedical risk, mucositis, the mode of transplantation, total body irradiation, age and gender. Psychological predictors were depression (BDI), BMT-related distress, chronic stress and resources in everyday life (KISS), pain-related coping behaviour (KPI-17) and social support (ISSS). Among the social variables we evaluated education, being married and the living situation. Criteria variables were the intensity of mouth pain and anxious mood which were assessed daily by numeric self-rating scales for 24 days after transplantation. Results of stepwise multiple regressions indicated that psychological and social variables were important predictors of mouth pain, besides biomedical variables. Whereas the biomedical variables revealed the most predictive power during the second week after BMT, psychological predictors were more important during the early and late phases of the treatment. Daily anxious mood was best predicted by psychological and social variables. Among the biomedical variables mucositis was most strongly related to mouth pain besides mode of transplantation, risk, TBI and age. Among the psychological variables BMT-related distress was the most important predictor, with resources in private life or at work and pain-related coping modes as further significant predictors. These results imply that relevant predictors should be assessed as high risk factors for an 
There has been substantial progress in the palliation of treatment-related side effects of high-dose therapy (HDT) and bone marrow transplantation (BMT) in the last decade. Patient-controlled analgesia has demonstrated positive effects on pain. 1 Nevertheless, patients undergoing these procedures still experience mild to severe mouth pain and also affective distress. Knowledge about the sources and interrelationships of these stressors has remained largely undefined.
Pain in cancer patients has generally been attributed to the tumor or to the treatment as the primary sources. The main origin of treatment-related pain during BMT is oral mucositis. It causes severe pain requiring morphine therapy in the majority of patients. In a study of 197 adult BMT patients Chapko and coworkers 2 found pain stemming from oral mucositis beginning several days prior to BMT and peaking during the second week post BMT (see also Refs 3 and 4). Mild to moderate pain persisted in most of the patients in spite of morphine therapy. Treatment-related pain has mostly been studied in a unidimensional manner, addressing only somatic nociceptive or pharmacologically treated components. Yet pain research recognizes pain not as a purely physical experience, but as involving 'complex aspects of human functioning including personality, affect, cognition, behavior and social relations . . . The challenge of untangling and addressing both the physical and psychological issues involved in pain is essential to developing rational and effective management strategies'. 5 As pain has been conceptualized as a consequence of cancer disease and treatment, effective distress such as anxiety or depression was mostly seen as a consequence of cancer or treatment-related pain. For example, the comparison of cancer patients with pain with cancer patients without pain revealed higher levels of anxiety and depression in those with pain. [6] [7] [8] One question in this field concerns the role of global measures of anxiety or depression such as the Beck Depression Inventory (BDI) vs more situationspecific measures. For example, Ahles et al 6 found pain to be related to pain specific anxious and depressive mood, but not to global depression. Also Schacham et al 9 found weak associations between pain and general mood. However, Glajchen et al 7 reported significant differences between pain and nonpain patients in various global distress variables, using the Profile of Mood States (PMS). Similarly Zimmerman and coworkers 8 described significant relations between pain and global affective distress variables using the Brief Symptom Inventory (BSI).
Looking at the relationship between pain and situationspecific stress or general life stress, findings are also ambiguous. Syrjala and Chapko 4 found a high positive correlation between treatment-related pain and situation-specific stress that was strongly related to the setting of bone marrow transplantation, whereas Koopman et al 10 found pain in breast cancer patients to be related with general life stress. Following the Conservation of Resources Theory, 11 Koopman and coworkers argued that patients who have experienced greater life stress would have to cope with more stressors reducing their resources for coping with stress. According to this theory both treatment-related stress factors and general life stress must have significant effects on negative mood.
During the last years the relationship between pain and social environment in cancer patients was investigated in only a few studies. Whereas variables such as social network and perceived social support predominantly were associated with positive mood or low negative affective distress, [12] [13] [14] no relationship was found for cancer or treatment related pain. 4, 10, 15 In contrast to this, negative significant associations have been reported for pain and the coping mode support seeking behaviour. Syrjala and Chapko 4 found a negative relationship between support seeking behaviour assessed before the start of bone marrow transplantation and treatment-related pain in women during the hospital stay. Also Koopman et al, 10 who did not find a relationship between social support and pain, discuss the necessity to better understand how patients develop and make use of social support in order to better cope with stress and to alleviate pain. Support seeking behaviour was rarely investigated in cancer patients, although studies in nonmalignant pain revealed this coping mode as a relevant predictor of the chronicity of pain (see for example Refs 16, 17) .
The relationship between pain and further coping strategies has also rarely been explored in cancer patients. Besides support seeking behaviour, Syrjala and Chapko 4 found wishful thinking to be negatively related to pain in female patients as well. This finding was in contrast to the literature in nonmalignant pain. Wishful thinking has frequently been associated with avoidance as a strategy not conducive to problem-solving and therefore not helpful in coping with stress. 18 In the setting of BMT, Syrjala and Chapko 4 supposed that when patients cannot solve pain or eliminate it through appropriate actions, it may be valuable to have the ability to imagine positive outcomes that would magically remove the problem. 4 In a cross-sectional study including 45 patients with pain related to lung cancer, pain quality variables assessed by the McGill-Melzack Pain Questionnaire (MPQ) 19 were positively associated with catastrophising, diverting attention, praying/hoping, and increased activity, all assessed by the Coping Strategies Questionnaire (CSQ). 20, 21 Pain-related coping strategies, such as extreme avoidance vs extreme suppressive behaviour (or increasing activities in spite of pain), as well as diverting attention have been seen as important risk factors of the chronicity of nonmalignant pain. 17, [22] [23] [24] One difficulty in the literature to date is the concurrent collection of psychosocial and pain measures so that the direction of effect is impossible to clarify. Does cancer or treatment-related pain increase affective distress and decrease the ability to develop potential adaptive coping behaviour or do affective distress, general life stress and coping behaviour modify the individual pain experience? From research in nonmalignant pain we can assume that both are true: patients who are more distressed and who have learned more maladaptive pain coping behaviour will be more vulnerable to greater pain perception and with greater nociception, patients become increasingly distressed. [24] [25] [26] To our knowledge, the study of Syrjala and Chapko 4 mentioned above, is the only prospective longitudinal study which attempted to systematically evaluate the influence of biomedical and psychosocial variables on the variance of cancer treatment-related pain. The authors considered the bone marrow transplantation setting as an opportunity to study a population of cancer patients who begin pain-free and develop persistent pain. Thus they looked at the direction of effect to determine whether psychological factors predict pain. Syrjala and coworkers conducted a large scale assessment of 358 BMT patients before, during and after treatment. The questionnaire included multiple measures of social, physical and psychological functioning, in conjunction with biomedical variables. After pretransplant assessment, prior to pain onset, patients completed daily visual analogue scale oral pain reports for 25 days following BMT. Opioid use and the degree of observable mucositis were assessed by medical staff. This study demonstrated that biomedical variables, especially oral mucositis, accounted for most of the variance in daily rated pain intensity. Psychosocial variables contributed only moderately, but significantly, to the variance in pain report. Among the psychological variables, BMT-specific distress measured before admission was the strongest psychosocial predictor, while coping behaviour was a weaker, but also significant predictor. Increased BMT distress, decreased self-efficacy and decreased support-seeking behaviour predicted more pain intensity during the treatment, wishful thinking as a further coping strategy was negatively correlated with pain.
In the present study, we try to confirm the results of Syrjala and Chapko 4 in a second prospective study in the field of BMT. We examine the predictive value of biomedical, psychological and social risk factors for an increase of mucositis-related pain following BMT. Additionally we evaluate the predictive power of the same precursor variables for daily rated affective distress (anxious and depressive mood) as criteria variables. We predict (1) that treatment-related pain as well as affective distress will be better explained by a combination of biomedical and psychosocial variables than by biomedical variables alone. Among the psychological predictors we additionally investigate the aspect of general or chronic stress in private life or at work, as well as resources in daily life which have been seen as significant predictors of the chronicity in nonmalignant pain (see Ref. 17) . With regard to the Conservation of Resources Theory described by Hobfall, 11 we predict (2) that actual BMT-related distress, as well as general life stress and resources, will be relevant predictors of treatment-related pain and affective distress after BMT. Furthermore we investigate pain-related coping behaviours instead of unspecific coping modes in order to increase the predictive power of these variables. We predict (3) that painrelated avoidance behaviour, as well as extreme suppressive behaviour and diverting attention and also the lack of seeking social support belong to important precursors of BMTrelated pain and affective distress. 17, 22, 23 With respect to the potential influence of social environment variables we include perceived social support, as well as the living situation (living alone vs living with others) as predictor variables. We predict (4) that perceived social support and living alone are relevant predictors for the amount of affective distress, but not for pain.
Patients and methods

Patients
The study was carried out in a prospective longitudinal design including a series of 63 patients receiving their first PBSCT/BMT at the BMT-center of the University Hospital in Hamburg-Eppendorf. Inclusion criteria were age over 18 years, hematological malignancies (no solid tumors) and fluent German. All subjects received standard psychosocial support during treatment.
Procedere and measures
Patients were contacted via letter explaining aims and procedures of the study and asked to sign informed consent. Patients were assessed twice before the start of medical treatment, in the outpatient department approximately 2 weeks before admission (T0) and on the BMT-ward at admission (T1). All assessments were completed on site with an interviewer present. Standardised psychological measures were completed using paper and pencil forms followed by a semi-structured individual interview. During the hospital stay the patients completed daily self-report measures of mouth pain, and anxious and depressive mood. Interviewers visited patients weekly on the BMT-unit to ask about possible difficulties with the diary. Medical documentation, as well as documentation of the mucositis index, was done by trained medical students in cooperation with senior physicians on the ward. All questionnaires and procedures were approved by the institutional review board of the Physicians Chamber of Hamburg.
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Biomedical measures
Information about the diagnosis, disease status, the treatment protocol and treatments prior to the BMT were abstracted from patient medical charts. Gender and age were obtained during the pre-admission assessment.
Risk: Risk was classified as high or low according to Syrjala and Chapko 4 focusing on the disease status and diagnosis. Low risk was defined as diagnoses of chronic phase myelogenous leukemia (CML), first remission acute nonlymphocytic leucemia (ANL), first remission acute lymphocytic leukemia (ALL) or preleukemic syndromes. Other diagnoses, patients in relapse after more than first remission, or not in chronic phase were classified as high risk.
Features of treatment:
Total body irradiation has been included as a possible predictor variable as Schubert et al 27 found TBI as a predictor of mucositis and Syrjala and Chapko 4 found TBI as a preditor of mouth pain. Further, we included the mode of transplant, either bone marrow or peripheral stem cells. Conditioning was as follows: for CML, Bu/Cy resp TBI/Cy; for AML, Bu/Cy/VP16; for ALL, TBI/Cy/VP16; for myeloma (auto), TMI/Bu/Melph resp. Bu/Melph; for myeloma (allo), TMI/Bu/Cy resp Bu/Cy (Bu: busulfan; Cy: cyclophosphamide; Melph: melphalan).
Mucositis index:
The mucositis index was rated by trained medical students every second day during the inpatient treatment. (One week of training for medical students took place before the start of the study: Students were trained daily by senior assistants being familiar with the mucositis index, because it is used in the daily documentation of patient complaints. Senior assistants and students rated mucositis independently and compared individual results. Finally medical students could use the mucositis index autonomously.) This measure was developed by Lorentz et al. 28 The extent of tissue damage is rated from 0 (normal) to 6 (necrosis, etc) for six distinct areas of mouth and throat, and a global score (maximum, 36) is calculated. The data were aggregated to a sum score.
Opioid use: Analgesics were given intravenously according to the status of mucositis and the pain expressed by the patient. Morphine and additional analgesics were recorded daily and converted to morphine equivalents using the conversion factors of Stimmel. 29 Daily morphine data were aggregated to weekly means.
Measures risk, TBI, mode of transplant, and mucositis were used as predictor variables. Opioid use was not included as a predictor variable because patients and medical staff directed opioid administration and it is a consequence rather than a precursor to pain.
Psychological predictor variables
Depression: Depression corresponding to psychiatric classifications, was assessed by the Beck Depression Inventory BDI. 30 The BDI is a 21-item self-report measure assessing the incidence of various symptoms of depression. It has demonstrated excellent reliability and validity, as well as the ability to discriminate depressed from nondepressed patient pain. 31 It has also been used in several psycho-oncological, especially BMT, studies (for example 6, 32, 33 ). In the current study, the German version from Kammer 34 was used, which is comparable to the English version.
Treatment-specific distress:
The BMT-Distress Questionnaire (Ref. 32 ; translated with permission from the authors) was developed to measure specific stressors in BMT patients before treatment. It comprises 35 items concerning potential stressors such as loss of hair, pain, nausea or not knowing what the future will bring. Items are scaled from 0 = no distress to 3 = severe distress and summed to a global distress score. The internal consistency is ␣ = 0.91 for the German version. For statistical analysis we use the sum score.
Chronic stress and resources in everyday life: Chronic stress and resources in 15 areas of daily living were assessed by the Kiel Interview of Subjective Situation KISS. 35 The life areas include physical and mental demands at work, contact with the chief and colleagues, housework, partnership and family, relationship to friends and relatives, leisure time. Patients who are not employed rated how they felt without their work, colleagues and chief. They are scored on two seven-point scales each concerning their resourcefulness (0 = not resourceful at all, to 6 = very resourceful) or stressfulness (0 = not stressful at all, to 6 = very stressful). The retest reliability was about r = 0.75. The KISS was validated in several prospective studies in cancer and noncancer pain research. 17, 36 Coping with pain: The Kiel Pain Inventory-17 (KPI-17) is a short version of the Kiel Pain Inventory, 37 an assessment validated in studies with chronic low back pain patients. The full version contains nine factor analytically derived scales concerning aspects of coping with pain. The short version consists of 17 core items of this measure, representing the scales Avoidance, Diverting Attention, Suppression and Seeking Support. Pain coping items are scored separately on seven-point scales from 0 = never used to 6 = always used. Internal consistency (Cronbach's alpha) of the scales of the short form varied between 0.71 and 0.79.
Social support:
The Illness-Specific Social Support Scale (ISSS) 38 was translated and modified in cooperation with the authors 39 and proved to have a good reliability (␣ = 0.91) and validity.
Social predictor variables
Social measures such as the living, educational and occupational situation were obtained using self-reports. As predictors, the partner situation was coded as 0 = living alone or 1 = living together (with spouse, partner, parents, etc). Education was coded according to Table 1 . ALL = acute lymphocytic leukemia; AML = acute myeloid leukemia; CML = chronic myelogenous leukemia; MT = marrow transplantation; BMT = bone marrow transplantation; PBSCT = peripheral blood stem cell transplantation; TBI = total body irradiation.
Inpatient outcome measures
Numerical Rating Scales (NRS) were used to rate mouth pain, anxious mood and depressive mood from '0' (no pain, no anxious mood, no depressive mood) to '6' (severe pain, anxious or depressive mood). Patients completed these scales each day in the hospital until discharge. NRS Pain and Distress scores have been shown to be reliable and valid measures in pain research. [40] [41] [42] The daily measures for each scale were used to compute week means for week 1 (days 0 to +7 after BMT), week 2 (days 8 to 14), and week 3 (days 15 to 21).
Statistical analyses
Scores for each measure were examined and highly skewed distributions were normalised with log transformations. Analysis of variance (ANOVA) for repeated measures was used to assess changes in the criteria scores over time for those individuals who could be tested at all time periods. Post hoc univariate statistics (t-tests) were used to compare the subjects at each time point. Pearson product moment correlations and nonparametric correlation coefficients were used to examine the bivariate relationships between the predictor variables and daily mouth pain, anxious and depressive mood. In accordance with Syrjala and Chapko 4 stepwise multiple regressions were conducted for biomedical variables alone and in a second step for all predictor variables. Analyses were performed using the Statistical Package for the Social Sciences (SPSS). Table 1 shows the patient characteristics: two-thirds were male, ages ranged from 19 to 61, with a mean of 40 years. The educational levels were equally distributed, most patients lived together with the spouse, partner or parents, almost one-third lived alone. 50% of the patients were diagnosed with CML (chronic myelogenous leukemia). The largest part of the sample received allogeneic transplants, including marrow of related and unrelated donors. Peripheral blood stem cell transplantation was conducted in 19% of the patients. The sample was classified regarding high or low risk regarding the classification of Syrjala et al. 33 About two-thirds were low, one-third high-risk patients. TBI was part of the conditioning regimen for 27 patients; half had undergone chemotherapeutic treatment prior to BMT. Table 2 shows the results of the psychological measures at T0. Depression, assessed by the BDI was rare in this sample, as indicated by a low BDI-mean of 7.25. According to the clinical cut-off scores, three patients had elevated levels of depression of over 16. Regarding Social Support, BMT recipients described themselves as having high Positive Support (Mean = 3.25 on a scale ranging from 0 to 4). With respect to pain-related coping behaviour, Suppression and Diverting Attention were used more often compared to Avoidance and Support Seeking Behaviour. The patients reported more Resources than Stress in Everyday Life. Nevertheless, nine patients reported considerable Chronic Life Stress with means over 3. Table 3 as well as Figure 1 show the time courses of Mucositis, Morphine Intake, Pain, Daily Anxious and Depressive Table 3 Weekly means, standard deviations and minimum/maximum scores for expert-rated mucositis (possible range from 0 to 36) and morphine equivalents (possible range from 0 to 155 mg) and of self-rated daily mouth-pain, anxiety and depressive mood (potential range 0 to 6) during 3 weeks after treatment Mood throughout the 3 weeks after transplantation. In order to compare these measures, in Figure 1 all scores were shown as z-score equivalents. ANOVA for repeated measures showed significant changes over time for Mouth Pain (P Ͻ 0.001), for Mucositis (P Ͻ 0.001) and for Morphine Intake (P Ͻ 0.001), but not for Anxious and Depressive Mood. The most severe Mucositis occurred, as previously reported, 4 in the 2nd week post-BMT with a mean of 13 and five subjects Ͼ20. During week 3, Mucositis declined to a mean of 6.3, but there were still patients with scores up to 23. The Morphine Intake followed this pattern closely (see Table 3 and Figure 1 ). The daily self-rated Mouth Pain also revealed the same pattern as Mucositis and Morphine intake. The highest score (3.28) was reached in week 2 with 20 individuals rating strong to most severe pain of 4 to 6. It is notable that there were nine patients who did not report Mouth Pain during the phase of severe mucositis, although they did not receive morphine. A different pattern was seen for Anxious and Depressive Mood: the weekly means were low, under 2, in all phases of the treatment. The daily self rated variables Anxious and Depressive Mood displayed high intercorrelations for all three weeks (mean r = 0.88). We therefore decided to inspect only Anxious Mood as one of these variables in the following correlational analyses. 
Results
Patient characteristics
Results concerning time course of pain and mood
Bivariate relationships between predictors and the criteria variables
Levels of significance:
+ P Ͻ 0.10, P Ͻ 0.05, **P Ͻ 0.01, ***P Ͻ 0.001. BMT = bone marrow transplantation; PBSCT = peripheral blood stem cell transplantation; TBI = total body irradiation; BDI = Beck Depression Inventory; KISS = Kiel Interview for the Subjective Situation; KPI-17 = Kiel Pain Inventory Short Form; ISSS = Illness-specific Social Support Scale.
Daily Anxious Mood was only related to psychological and social variables, not to the biomedical variables. It was most closely related to BMT-Distress (all r Ͼ 0.40), secondly most to the resources in everyday life (all r Ͼ −0.27). There was a tendency to a positive relationship between Chronic Stress in Everyday Life and Anxious Mood, but the coefficients did not reach significance. BDI-Depression was significantly related to Anxious Mood in week 1 after BMT and as a tendency in week 3. There was also a tendency to a significant relationship between Living Situation and Anxious Mood in all 3 weeks after BMT. While Mouth Pain in week 2 was best predicted by biomedical variables, Mouth Pain during week 1 and week 3 were better predicted by a combination of all variables. The total variance explained by all predictors ranged from 44 to 47%. Comparing the R 2 s, we can see that Mouth Pain during week 2 was best predicted by the biomedical variables and among these, Mucositis followed by TBI/chemo and PBSCT/BMT are the relevant predictors. Mucositis was correlated positively with Mouth Pain whereas, in con-347 Table 5 Results from stepwise regression analyses (R 2 s and beta weights) predicting mouth pain and anxiety in each of three time periods The affective distress variable Anxious Mood during the inpatient setting was merely predicted by the psychological and social variables assessed prior to BMT. The total variance explained by all predictors ranged from 29% to 36%. The amount of Daily Anxious Mood during all phases of treatment was best predicted by BMT-Distress prior to BMT. The more the patients had experienced BMT-Distress prior to BMT the higher the anxiety scores following BMT. Anxious Mood in week 1 and 3 was further predicted by the amount of Resources in Daily Life. The more resources patients experienced in their life 6 months before BMT, the less anxious they felt after BMT. Among the pain-related coping modes, Diverting Attention revealed significant predictive power. The more patients tended to divert their attention from pain, the more they felt anxious after BMT. Finally, patients who lived alone experienced more anxiety after BMT than patients who lived together with one or more people. The information revealed by the BDI-Depression score and Pain-Related Avoidance in the bivariate correlations seemed to be redundant in the multivariate analyses. The potential predictors Risk, Social
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Support, Pain-Related Suppression and Education did not demonstrate any predictive value in the multivariate analyses.
Discussion
The results provide support for our first and main hypothesis that a biopsychosocial model will better predict cancer treatment-related pain and distress than a strictly biomedical model. We confirmed the results of a first prospective study in the field of BMT and cancer treatment-related pain, conducted by Syrjala and Chapko. 4 The total amount of explained variance in Mouth Pain ranged from 44 to 47% with psychological predictors most relevant during the early and late phases of the treatment. Daily rated Anxious Mood was best predicted by psychological and social variables, the biomedical variables did not add further predictive power.
Regarding the descriptive data first, results showed patterns of mucositis, mouth pain, and morphine intake comparable to those of Gaston-Johannson et al 3 and Syrjala et al. 32, 33 Mucositis began substantially during the first week after BMT, rose distinctly in week 2 and then declined again to tolerable levels. Mucositis-Related Pain and Morphine Intake followed this pattern. Mild to moderate mouth pain occurred in spite of morphine therapy. Whereas Mouth Pain, Mucositis and Morphine Intake changed over time significantly, Daily Anxious and Depressive Mood were low and did not change over time after BMT. Due to the very high relationship between Daily Anxious and Depressive Mood we decided only to assess Anxious Mood as one of these variables in the correlational analyses.
Additionally we compared the predictive power of situation-specific stress vs more general chronic stress in private life or at work and included pain-specific coping behaviour instead of general coping modes in order to increase the predictive value of the coping variables. In accordance with the Conservation of Resources Theory described by Hobfall, 11 we also investigated the predictive value of resources in everyday life. Finally we compared the role of social support vs support-seeking behaviour in the prediction of mouth pain and anxiety.
In the prediction of mouth pain the biomedical variables Mucositis, Age, PBSCT/BMT and TBI belong to the relevant predictors of pain in week 2 with higher pain scores in patients showing more severe mucositis, older age, no TBI and no PBSCT (but BMT). Regarding transplantation of bone marrow vs peripheral blood stem cells, there are no empirical data indicating a moderating influence on the degree of mucositis. The negative relation of PBSCT to mouth pain is, therefore, surprising. The same is true for the influence of TBI vs chemotherapy. Syrjala and Chapko 4 observed a significant effect of TBI on mouth pain only in the first week after BMT. The paper gives no details of the doses of total body irradiation, but to our knowledge higher doses of 16 Gy were usual at that time, whereas our patients received only 12 Gy. In the vast majority of cases without TBI, busulfan was given. It could be possible that the mucosa toxicity of busulfan was higher than that of TBI at 12 Gy.
Results regarding psychological predictors partly provide support for our second hypothesis. Bivariate correlations indicated positive predictive power for situation-specific BMT-Distress, as well as for general BDI-Depression. In the multiple regressions BDI-Depression displayed significant beta-values for pain in week 1, BMT-Distress was predictive for pain in week 3. In contrast to our hypothesis, more general chronic life stress did not reach significance, although bivariate correlations showed a tendency to positive relationships between pain and general stress in week 1 and 3.
According to our third hypothesis, the pain-related coping modes Avoidance and Support Seeking were found to be relevant predictors of pain in week 1. The more the patients tended to avoid pain and the less they tended to seek social support when they had pain in everyday life, the more they suffered from treatment-related mouth pain in the early phase of the treatment. Avoidance behaviour is a well-known maladaptive pain coping strategy, described in the Fear-Avoidance Model of Pain. 43 It supposes that avoidance of social and physical activities will lead to physical inactivity, social withdrawal and increased depressive mood. The model further assumes complex relationships between avoidance and pain due to modified endocrinological parameters (eg decreased secretion of endorphine under depressive mood and therefore an increased sensitivity for pain) and several physical aspects (for example physical inactivity will lead to muscular insufficiency with the phenomenon that even normal physical movements will cause pain due to increased neurophysiological processes of sensitization). Also, support-seeking behaviour has been shown as a relevant predictor of pain in cancer patients, 4, 10 as well as in non-cancer patients. 17 This means that patients with high scores on support-seeking scales will be able to ask for instrumental help when they have pain, or to ask for medication so that pain relief will be possible. It also means that patients will ask for emotional support, for example to ask for comfort. We assume that the ability to ask for these instrumental and emotional forms of support will lead to pain relief by taking the pain as a signal for the necessity of physical release, more effective medication or of emotional relaxation elicited by comfort and emotional nearness. In contrast to our third hypothesis, the pain coping modes Diverting Attention and Suppression did not reveal any predictive power regarding mouth pain. At first sight, this result seems confusing. Research on these coping modes has shown that patients with Attention Diversion and suppressive pain coping behaviour will reveal more cancer pain, 41 as well as more chronic non-malignant pain. 16, 17, 22 It was assumed that patients attempting to distract from pain or to suppress pain in order to finish activities in spite of pain will often fail and that these failures will lead to feelings of frustration, anxiety and depression. 44 Furthermore, Johnson and Petrie 44 argue that an individual using attention diversion strategies for coping with pain might turn off warning signals and without this feedback may exacerbate the injury accompanied by increasing pain. The same effect was expected from suppressive coping strategies. Patients try to suppress their pain experience in order to finish all the activities they started in spite of severe pain. 17, 45 Whereas these effects seem to be plausible for clinically relevant pain in everyday life, the specific situation in the BMT setting may change the adaptiveness of pain-related coping behaviour. In this situation, ignoring pain as a warning signal will not lead to an exacerbation of the injury which would be accompanied by increasing pain. In the specific situation of transient treatment-related pain, Attention Diversion could be an adaptive coping behaviour. Indeed, a pain decreasing effect of attention diversion techniques has been shown in intervention studies using guided imagery in addition to relaxation techniques in order to reduce BMT-related mouth pain significantly. 32, 33 The fact that we did not find negative relationships between Attention Diversion and pain in our study merits further consideration. In accordance with others, 6, 46 we assume that pain-related attention diversion strategies patients display in their daily life will differ from professional scheduled techniques. Whereas professional scheduled techniques are accompanied by mental and physical relaxation, in everyday life these coping strategies will be accompanied by increased physical activities and therefore by increased muscular tension. In the special BMT setting, patients do not have the opportunity to increase their activity because the special treatment setting leads to physical inactivity.
Results of the present study also provide support for our fourth hypothesis, that Perceived Social Support was not a relevant predictor for mouth pain after BMT. Most studies in the field of cancer pain did not reveal a relationship between social support and pain, 4, 10, 15, 47 although most studies indicated a relationship between support variables and less affective distress. [12] [13] [14] Perceived Social Support, assessed by standardised questionnaires may possibly lead to conflicting effects especially in the field of bone marrow transplantation. Neuser 48 found that the more people who offered help to the patients during hospitalisation, the higher the emotional distress in patients, especially in those with high general life stress. He argues that potential positive support can be associated with negative effects if too many people have contact with the patients during hospitalisation. In this case social support offered by relatives and friends will not fit the individual needs of the patients. The result of our study which demonstrates individual supportseeking behaviour was being a better predictor of pain than Perceived Social Support can also be interpreted on this background. The ability to show adequate support-seeking behaviour may potentially guarantee a better fit between individual needs and the support patients receive in this special situation. The finding that the variable Living Alone vs Living With a Partner (spouse or friend) predicted Pain as well as Daily Anxious Mood after BMT was in accordance with the literature which shows that the presence of at least one significant other party is positively related to mental and physical health. 49, 50 The results of our study also provide support for the hypothesis that a biopsychosocial model will better predict Daily Anxious Mood after BMT than biomedical variables alone. The psychological and social predictor variables particularly revealed statistical relevance. The results indicate that patients who tend to have higher pretransplant BDI-Depression scores, who perceive fewer Resources in Everyday Life, who tend to pain-related Avoidance and Attention Diversion behaviour, who experience more BMT-Distress and who live without a spouse or friend, are vulnerable to developing anxiety after BMT. In the multivariate regressions BMT-Distress, Resources in Daily Life, Diverting Attention and Living Alone displayed independent predictive power. BDI-Depression is a well known precursor of increased affective distress in the course of an organic disease. 51 The fact that Resources in Everyday Life was a better predictor than General Life Stress was in accordance with the Conservation of Resources Theory of Hobfall. 11 The author assumes that people strive to retain, protect and build resources and that what is threatening to them is the potential or actual loss of valued resources. Resources in Everyday Life must thus be a more relevant predictor of pain and affective distress than Chronic Stress alone. The adverse effect of diverting attention strategies in coping with pain is discussed above. The results support the hypothesis that the individual attempts of the patients to distract their mind from pain may often fail and that these failures lead to frustration and anxiety. Surprisingly, the biomedical variables assessed in our study did not predict the amount of anxiety after BMT, as was assumed in several cross-sectional studies described above. [6] [7] [8] The amount of reported Daily Anxious Mood was low in general in our study and depended primarily on individual psychosocial vulnerability.
In conclusion, it can be stated that subjectively experienced physical and emotional complaints, such as pain and Bone Marrow Transplantation anxious mood immediately after BMT can be explained by a combination of biomedical, psychological and social variables. Neither pain nor anxious mood are merely consequences of the biomedical situation of the patients. These inner states are substantially modulated by psychological and social factors, such as situational and chronic stress, lack of resources in daily life, maladaptive pain-related coping modes and the living situation. Most of the predictors can be assessed prior to treatment as risk factors for a specific vulnerability of these patients to treatment-related side-effects and emotional distress. As former studies have shown, psychological treatment modalities, including relaxation and imagery are able to reduce treatment-related pain and emotional distress 32, 33 in addition to morphine therapy. The results of our study suggest the recommendation of these supportive techniques to all patients who are at risk of increased treatment-related distress.
Nevertheless, the results have to be considered with some caution. The stepwise multiple regressions are sensitive to specific interactions of the variables included. In order to gain maximum comparability with the study of Syrjala and Chapko, 4 the only well controlled prospective study published in this field, we decided to also use stepwise regressions for multivariate analyses. We certainly included the same predictor variables in all the analyses; nevertheless, the results are potentially influenced by special confounding and suppressor effects of single predictors. As our study is merely the second prospective study in the field of BMT-related pain and distress, future research should try to formulate hypotheses about special confounding and suppressor effects that have to be tested differentially. Another limitation of this research is that only four painrelated coping modes were assessed. Therefore, we cannot evaluate the effect of other coping modes, such as wishful thinking, catastrophising, praying and hoping, coping selfstatements and nonverbal pain behaviour. On the other hand, this is a weakness of many studies examining painrelated coping. Most studies use different instruments to assess coping so that the comparability of the results is limited. Future research should gain higher accordance in using a comparable selection of questionnaires for the assessment of relevant predictors. A further important topic of research should be the development of a screening instrument for assessing individual risk of suffering from BMT-related pain in spite of morphine therapy and suffering from increased affective distress following BMT. The knowledge of an increased risk for suffering during the early and late phases of treatment would be a principle presupposition for offering adequate professional psychological support for these patients.
